Bill Commons

MD HB 334

died on adjournment

State Procurement - Constitutional Violations - Prohibited

Maryland · 2026 Regular Session · lower

Quick answers

Did MD HB 334 pass?

No. MD HB 334 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-28): Hearing 2/10 at 1:00 p.m.

What is MD HB 334 about?

MD HB 334 is a bill in the 2026 Regular Session titled “State Procurement - Constitutional Violations - Prohibited”.

Who sponsors MD HB 334?

Wims, Terrasa, Taveras and 12 others are the primary sponsors of MD HB 334.

Introduced
Latest action
2026-01-28 — Hearing 2/10 at 1:00 p.m.
Bill type
bill
Last updated

Sponsors

  • Wimsprimary
  • Terrasaprimary
  • Taverasprimary
  • Steinprimary
  • Pasteurprimary
  • Morenoprimary
  • Martinezprimary
  • Lewisprimary
  • Lehmanprimary
  • Kaufmanprimary
  • Hillprimary
  • Forbesprimary
  • Addisonprimary
  • Charkoudianprimary
  • Ruthprimary

Committees

Not provided by source.

Action timeline

  1. 2026-01-19

    First Reading Government, Labor, and Elections

    referral-committee

  2. 2026-01-28

    Hearing 2/10 at 1:00 p.m.

Versions

  • First - State Procurement - Constitutional Violations - ProhibitedCompare
  • (document, no version)Compare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:23:32.621655Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MD&identifier=HB 334. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.